Applied Biological Laboratories Overview
- Founded
-
2016
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$6M
- Investors
-
1
Applied Biological Laboratories General Information
Description
Operator of a biotechnology company intended to specialize in the research, development, manufacturing, and distribution of healthcare products. The company's products fortify the respiratory system with bioactive molecules, many of which the body already uses, this effectively stops viruses and bacteria in their tracks, preventing them from entering the system and infecting cells, enabling patients in protecting against and recovering from respiratory ailments
Contact Information
Website
www.appliedbioinc.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 760 Parkside Drive
- 317 Brooklyn
- New York, NY 11226
- United States
Applied Biological Laboratories Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 14-Sep-2020 | $6M | 000 | 0000 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 27-May-2016 | 000 | 000 | 000 | Completed | Generating Revenue |
Applied Biological Laboratories Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-3 | 000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 0.000 | |
| Series B-2 | 000,000 | 00.000000 | 00 | 00 | 00 | 00 | 0.000 | |
| Series B-1 | 504,952 | $0.001000 | $3.96 | $3.96 | 1x | $3.96 | 12.62% | |
| Series A | 495,048 | $0.001000 | $4.04 | $4.04 | 1x | $4.04 | 12.38% |
Applied Biological Laboratories Patents
Applied Biological Laboratories Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220313710-A1 | Compositions and methods using non-steroidal anti-inflammatory drugs | Pending | 22-Aug-2019 | 0000000000 | |
| AU-2020333973-A1 | Compositions and methods using non-steroidal anti-inflammatory drugs | Pending | 22-Aug-2019 | 0000000000 | |
| CA-3151044-A1 | Compositions and methods using non-steroidal anti-inflammatory drugs | Pending | 22-Aug-2019 | 0000000000 | |
| EP-4017488-A1 | Compositions and methods using non-steroidal anti-inflammatory drugs | Pending | 22-Aug-2019 | 0000000000 | |
| CA-3075988-A1 | Compositions and methods for protecting against airborne pathogens and irritants | Pending | 30-Aug-2017 | A61K45/06 |
Applied Biological Laboratories Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Michael Latefi | Co-Founder, President, Board Member & Chief Executive Officer | ||
| Nazlie Latefi Ph.D | Co-Founder & Chief Scientific Officer |
Applied Biological Laboratories Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Michael Latefi | Applied Biological Laboratories | Co-Founder, President, Board Member & Chief Executive Officer | 000 0000 |
Applied Biological Laboratories Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Applied Biological Laboratories Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |